SII is working on an Omicron-specific vaccine, may launch it by the end of this year: Report

SII Chief Executive Officer Adar Poonawalla told NDTV that the vaccine is being developed in collaboration with Novavax. Poonawalla further said that the vaccine will be specific to the BA5 sub-variant of Omicron.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/McG32z8
via IFTTT